GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (WBO:AFX) » Definitions » 3-Month Share Buyback Ratio

Carl Zeiss Meditec AG (WBO:AFX) 3-Month Share Buyback Ratio : 0.00% (As of Dec. 2024 )


View and export this data going back to 2017. Start your Free Trial

What is Carl Zeiss Meditec AG 3-Month Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Carl Zeiss Meditec AG's current 3-Month Share Buyback Ratio was 0.00%.

Competitive Comparison of Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio, along with its competitors' market caps and 3-Month Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio falls into.


;
;

Carl Zeiss Meditec AG 3-Month Share Buyback Ratio Calculation

Carl Zeiss Meditec AG's 3-Month Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

3-Month Share Buyback Ratio=(Shares Outstanding (EOP) (Sep. 2024 ) - Shares Outstanding (EOP) (Dec. 2024 )) / Shares Outstanding (EOP) (Sep. 2024 )
=(87.536 - 87.536) / 87.536
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG  (WBO:AFX) 3-Month Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Carl Zeiss Meditec AG 3-Month Share Buyback Ratio Related Terms

Carl Zeiss Meditec AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (WBO:AFX) » Definitions » 3-Month Share Buyback Ratio
Comparable Companies
XTER:FIE XTER:1SXP XTER:GXI ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN HOLX NZSE:FPH SOLV
Traded in Other Exchanges
CZMWY:USA CZMWF:USA 1AFX:Italy AFXd:UK 0DHC:UK AFX:Germany AFX:Bulgaria
Address
Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Website
https://www.zeiss.com
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG Headlines

No Headlines